Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Rent ExpenseShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

RemSleep Holdings (RMSL) Shares Issued (2016 - 2024)

RemSleep Holdings recorded quarterly Shares Issued of $25000.0 in Q4 2024, down 90.91% quarter-over-quarter from $275000.0 in Q3 2024.

RemSleep Holdings' Shares Issued history runs 5 years deep, the most recent figure standing at $25000.0 for Q4 2024.

  • In Q4 2024, Shares Issued changed N/A year-over-year to $25000.0; the TTM figure through Dec 2024 stood at $300000.0 (changed N/A YoY), while the FY2024 annual figure was $420000.0, changed N/A from the prior year.
  • Shares Issued came in at $25000.0 for Q4 2024 at RemSleep Holdings, down from $275000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.0 million in Q3 2021 to a low of $25000.0 in Q4 2024.
  • A 3-year average of $832500.0 and a median of $855000.0 in 2022 frame the typical range for Shares Issued.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 116.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 164.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 81.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 68.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 12.70 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 RemSleep Holdings - - -7,636.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 25,000.00
Dec 31, 2024 25,000.00
Sep 30, 2024 275,000.00
Sep 30, 2024 275,000.00
Mar 31, 2022 855,000.00
Mar 31, 2022 855,000.00
Dec 31, 2021 1.06 Mn
Dec 31, 2021 1.06 Mn
Sep 30, 2021 1.95 Mn
Sep 30, 2021 1.95 Mn
Sep 30, 2018 12,500.00
Sep 30, 2018 12,500.00
Mar 31, 2018 77,500.00
Mar 31, 2018 77,500.00
Dec 31, 2016 27,000.00
Dec 31, 2016 27,000.00